Stryker received FDA 510(k) clearance for the MultiGen 2 RF Generator for radiofrequency ablation to treat facet joint pain.
MultiGen 2 is part of Stryker’s Performance Platform, comprising the generator, Venom Cannula and Electrode System, engineered to provide twice the industry standard for power to reach its target temperature faster and with fewer errors.
Source: Stryker Corp.
Stryker received FDA 510(k) clearance for the MultiGen 2 RF Generator for radiofrequency ablation to treat facet joint pain.
MultiGen 2 is part of Stryker's Performance Platform, comprising the generator, Venom Cannula and Electrode System, engineered to provide twice the industry...
Stryker received FDA 510(k) clearance for the MultiGen 2 RF Generator for radiofrequency ablation to treat facet joint pain.
MultiGen 2 is part of Stryker’s Performance Platform, comprising the generator, Venom Cannula and Electrode System, engineered to provide twice the industry standard for power to reach its target temperature faster and with fewer errors.
Source: Stryker Corp.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.






